Skip to main content
Clinical Trials/NL-OMON43323
NL-OMON43323CompletedPhase 4

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a pilot study - M&M trial

Radboud Universitair Medisch Centrum0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
40

Study Overview

Brief Summary

Trial is onging in other countries

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • * Early pregnancy failure, 6-14 weeks postmenstrual with a
  • o Crown-rump length * 6mm and no cardiac activity OR
  • o Gestational sac without embryonic pole, confirmed by a second ultrasound at least one week later
  • * At least one week after diagnosis OR a discrepancy of at least one week between crown-rump length and calendar gestational age
  • * Intra-uterine pregnancy
  • * Women aged above 18 years
  • * Hemodynamic stable patient
  • * No signs of infection
  • * No signs of incomplete abortion
  • * No contraindications for mifepristone or misoprostol
  • * No high risk of thrombosis

Exclusion Criteria

  • Patient does not meet inclusion criteria, discovered after randomization
  • Inability to give informed consent

Investigators

Similar Trials

Mifepristone and misoprostol versus... | Clinical Trial